Improving the treatment of Epstein-Barr virus infectious mononucleosis in children

Journal Title: Актуальна інфектологія - Year 2018, Vol 6, Issue 2

Abstract

Background. In Ukraine, as in the whole world, there is a tendency to increase in the number of diffuse liver diseases. Increased percentage of patients with liver disease among adults is mostly determined by the damages to hepatobiliary system in childhood. The purpose of the study was to evaluate the effectiveness of ursodeoxycholic acid (UDCA) in the therapy of liver damages due to Epstein-Barr virus (EBV). Materials and methods. Research design: prospective, open-label, controlled. Sixty children with EBV infectious mononucleosis (IM) aged 1 to 18 years old were screened. All patients were observed, examined during the acute period of the disease, and divided into 2 groups. The children of the main group (n = 35) received standard therapy for EBV IM in combination with UDCA, patients of the control group (n = 25) received standard treatment alone. Results. Received data showed that therapy improved by means of UDCA in EBV IM and liver damage promotes a faster regression of the main symptoms of infection, such as fever, appetite loss and jaundice, already on day 7 from the beginning of treatment and a more rapid norma­lization of indicators of the functional state of the liver (alanine aminotransferase, bilirubin, alkaline phosphatase, gamma glutamyltransferase, lactate dehydrogenase). The drug was well tolerated, no adverse reactions were observed. Conclusions. The inclusion of UDCA in the treatment scheme can improve the effectiveness of advanced therapy compared with standard one, promotes a more rapid regression of infection symptoms and a more rapid norma­lization of indicators of the functional state of the liver.

Authors and Affiliations

S. O. Кramarov, V. O. Shadrin, V. V. Yevtushenko, I. V. Shpak, L. A. Bolshakova, Т. M. Kaminskaya

Keywords

Related Articles

Clinical Features of Newly Diagnosed Pulmonary Tuberculosis Depending on the Type of Functional Activity of the Thyroid Gland

The article presents the data on clinical features of pulmonary tuberculosis depending on the functional activity of the thyroid gland. It is found that in patients with impaired thyroid homeostasis, severe general condi...

Analysis of the risk factors for pulmonary tuberculosis in ATO participants, the clinical course, diagnosis and dependence on them of the duration of treatment

Background. The incidence of tuberculosis (TB) among military personnel is constantly increasing due to the antiterrorist operation (ATO) (deterioration of living conditions, irregular food, disturbed sleep and rest, sta...

Rare case of chiasm glioma in woman with hypogonadotropic hypogonadism and obesity

Chiasm glioma is a rare disease characterized by a decrease in the visual field. The aim of research was to describe a clinical case of chiasm glioma with concomitant hypogonadism and obesity. Reproductive function in 25...

Improving the treatment of Epstein-Barr virus infectious mononucleosis in children

Background. In Ukraine, as in the whole world, there is a tendency to increase in the number of diffuse liver diseases. Increased percentage of patients with liver disease among adults is mostly determined by the damages...

Nifuroxazidum for a Complex Therapy of Diarrhea in Infants

There was studied the direct antimicrobial effect of nifuroxazidum for a complex treatment of diarrhea in infants. Nifuroxazidum in therapeutic doses has a bacteriostatic activity and in high doses it has a bactericidal...

Download PDF file
  • EP ID EP289583
  • DOI 10.22141/2312-413x.6.2.2018.131095
  • Views 82
  • Downloads 0

How To Cite

S. O. Кramarov, V. O. Shadrin, V. V. Yevtushenko, I. V. Shpak, L. A. Bolshakova, Т. M. Kaminskaya (2018). Improving the treatment of Epstein-Barr virus infectious mononucleosis in children. Актуальна інфектологія, 6(2), 87-92. https://europub.co.uk/articles/-A-289583